Venture Capital

Updated:

Avlar BioVentures

Avlar BioVentures is a venture capital firm based in Cambridge, United Kingdom, specializing in biotechnology investments. The firm manages $150 million and...

Avlar BioVentures

Avlar BioVentures is a venture capital firm based in Cambridge, United Kingdom, specializing in biotechnology investments. The firm manages $150 million and focuses on seed and early-stage opportunities in biopharmaceuticals, medtech, and biotechnology. Avlar BioVentures has completed 26 investments and achieved 8 portfolio exits through its various funds.

General information

Firm type

Venture Capital

AUM

$150 million

Location

Country

United Kingdom

City

Cambridge

Corporate office

Cambridge, United Kingdom

Sector focus

Venture CapitalUnited Kingdom

Frequently asked questions

What type of investments does Avlar BioVentures make?

Avlar BioVentures invests in seed and early-stage biopharmaceutical, medtech, and biotechnology opportunities.

How many investments and exits has Avlar BioVentures made?

Avlar BioVentures has made 26 investments and achieved 8 portfolio exits.

Profile maintained by using OSINT (open-source intelligence), regulatory filings, licensed data partners, and verified direct submissions. Read the methodology. Last updated: . Continuous refresh with full update cycles at least every 30 days.

Need institutional-grade insight on venture capital firms?

Altss delivers:

Principals with verified direct contactsAllocation history by asset classOSINT-derived deal signals
Book a demo

Prefer a guided tour?

We’ll walk you through:

Interactive funding timelinesCustom mandate & allocation filters
Book a demo

Browse by category

More Cambridge Venture Capital profiles